Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Randomized, Multiple-center, Double-blind, Placebo-controlled Study of the Safety and Analgesic Efficacy of Repeated Dosing of PMI-150 (Intranasal Ketamine) to Treat Acute Post-operative Pain Following Orthopedic Trauma, Injury, or Surgery.


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00709436

Organisation Name: Hospira, now a wholly owned subsidiary of Pfizer

Overal Status: Completed

Start Date: June 2008

Last Update: January 11, 2012

Lead Sponsor: Hospira, now a wholly owned subsidiary of Pfizer

Brief Summary: The purpose of this research study is to evaluate the safety and analgesic efficacy of PMI-150 (intranasal ketamine) compared to placebo in patients with acute post-operative pain following orthopedic trauma, injury, or surgery.

Conditions:
  • Pain, Postoperative


Total execution time in seconds: 0.79455304145813